Resources
News

Michael K. Fee to Lead Verrill’s Nationally-Recognized Health Care and Life Sciences Practice Amidst Recent Changes

August 31, 2020 Press Releases

(August 31, 2020) – Verrill is pleased to announce Michael K. Fee as the new leader of Verrill’s nationally-recognized Health Care & Life Sciences Group. The Group has a long history of representing a broad range of providers, insurers, and other participants in the health care field. Fee joined the Group during the past year, bringing to it preeminent skills and experience as a white collar defense litigator and health care fraud and abuse advisor.

At the same time, Verrill is announcing the dissolution of a portion of its practice group focused on academic and clinical research matters. “We are naturally sorry to see colleagues in this niche field depart,” Fee commented. “But it will not impact Verrill’s longstanding and vibrant health care practice. We will continue to serve clients of all kinds who operate in the complex and highly regulated health care field.”

Verrill provides a full spectrum of legal services to organizations and individual professionals in health care. Through multidisciplinary collaboration, Verrill assists with critical matters like strategic affiliations and transactions, privacy and security, reimbursement, regulatory compliance, and the defense of health care industry players in government enforcement proceedings and litigation. The health care practice has experienced a great deal of growth over recent years, including the expansion of the health care and life sciences defense practice that Fee also leads.

“I am excited to lead such a strong array of attorneys with decades of experience and stature in the health care field. As our clients look to us now more than ever amidst the current pandemic, we will continue to serve the ever-evolving needs of our clients throughout New England and beyond, providing them with the highest level of client service and value they know and expect,” added Fee.

Verrill’s Health Care and Life Sciences Group and its Health Care Industry Group, composed of 20 Partners and Counsel, supported by energetic and talented associates, remain focused on using their unmatched knowledge and skill to deliver the highest level of client service to the firm’s health care industry clients from three of Verrill’s offices in New England.

Firm Highlights

Publication/Podcast

Hospital Price Transparency Rule: Full Steam Ahead

Neither COVID-19 nor continued legal challenges appear likely to derail the Centers for Medicare & Medicaid Services ( CMS) Hospital Price Transparency Rule from going into effect on January 1, 2021. Hospitals therefore should...

Matter

Multi-Site Global Research

Developed and negotiated site and coordinating center agreements in connection with a multi-site, international, National Institutes of Health (NIH)-funded study, and advised on regulatory issues related to the conduct of the study and subsequent...

Matter

Common Rule

Guided multiple clients through the implementation of the revised HHS regulations (the "Common Rule"), including reviewing and revising policies and procedures, and assisting with institutional approaches to implementation.

Matter

European Union GDPR—Institution

Counseled a preeminent health system and academic medical center on its compliance with the European Union General Data Protection Regulation (GDPR) in relation to its clinical and research activities, including its international research studies...

Publication/Podcast

FDA Issues Guidance on IRB Review of Non-Emergency Individual Patient Expanded Access Requests for Investigational Drugs and Biological Products to Treat COVID-19

Prompted by a substantial increase in requests for individual patient access to investigational drugs and biologics to treat COVID-19, the U.S. Food & Drug Administration (“FDA”) issued guidance on June 2, 2020 that outlines...

Publication/Podcast

EU-U.S. Privacy Shield Invalidated: Does Your Company Have a Plan B?

On Thursday, July 16, 2020, the Court of Justice of the European Union (“CJEU”) invalidated the EU-U.S. Privacy Shield (“Privacy Shield”) in Data Protection Commissioner v. Facebook Ireland and Maximillian Schrems (Case C-311/18...

Publication/Podcast

News Flash: HHS Issues Statement Removing Premarket Review Requirements for Laboratory Developed Tests (“LDTs”), Including COVID-19 LDTs

What happened? On August 19, 2020, the U.S. Department of Health and Human Services (“HHS”) issued a single paragraph statement rescinding U.S. Food and Drug Administration (“FDA”) guidance documents concerning premarket review of Laboratory...

Matter

Conflicts of Interest

Reviewed medical center's systems, policies and procedures for identifying, assessing, and managing investigator and institutional conflicts of interest.

News

Nearly 80 Verrill Attorneys Recognized by Best Lawyers® 2021, Including a Dozen Named Lawyers of the Year

(August 24, 2020) – Nearly 80 Verrill attorneys were recognized as "Best Lawyers" by Best Lawyers® 2021 , including 12 attorneys named “Lawyer of the Year,” a distinguished recognition for only a single lawyer...

Publication/Podcast

“If I've told you once, I've told you eight times…” HHS OIG Issues Another Audit Report on Hospitals’ Failure to Report Credits for Explanted Cardiac Devices and Lays the Groundwork Collection of Overpayments

Contact Verrill at (855) 307 0700